These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 956180)

  • 1. Reversible inhibition of glucose transport in human erythrocytes by a series of pyridine derivatives.
    Hershfield R; Richards FM
    J Biol Chem; 1976 Sep; 251(17):5141-8. PubMed ID: 956180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural requirements for binding to the sugar-transport system of the human erythrocyte.
    Barnett JE; Holman GD; Munday KA
    Biochem J; 1973 Feb; 131(2):211-21. PubMed ID: 4722437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Testing transport systems for competition between pairs of reversible inhibitors. Inhibition of erythrocyte glucose transport by cytochalasin B and steroids.
    Devés R; Krupka RM
    J Biol Chem; 1980 Dec; 255(24):11870-4. PubMed ID: 7440574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. WZB117 (2-Fluoro-6-(m-hydroxybenzoyloxy) Phenyl m-Hydroxybenzoate) Inhibits GLUT1-mediated Sugar Transport by Binding Reversibly at the Exofacial Sugar Binding Site.
    Ojelabi OA; Lloyd KP; Simon AH; De Zutter JK; Carruthers A
    J Biol Chem; 2016 Dec; 291(52):26762-26772. PubMed ID: 27836974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for allosteric inhibition sites in the glucose carrier of erythrocytes.
    Krupka RM; Devés R
    Biochim Biophys Acta; 1980 May; 598(1):127-33. PubMed ID: 7417421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for two asymmetric conformational states in the human erythrocyte sugar-transport system.
    Barnett JE; Holman GD; Chalkley RA; Munday KA
    Biochem J; 1975 Mar; 145(3):417-29. PubMed ID: 1156368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of anion and glucose permeabilities by anesthetics in erythrocytes. The mechanisms of action of positively and negatively charged drugs.
    Motais R; Baroin A; Motais A; Baldy S
    Biochim Biophys Acta; 1980 Jul; 599(2):673-88. PubMed ID: 6105880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of benzoic acid derivatives with the transport system of glucose in human erythrocytes.
    Lacko L; Wittke B; Zimmer G
    Biochem Pharmacol; 1981 Jun; 30(12):1425-31. PubMed ID: 7271838
    [No Abstract]   [Full Text] [Related]  

  • 9. Anomalous transport kinetics and the glucose carrier hypothesis.
    Regen DM; Tarpley HL
    Biochim Biophys Acta; 1974 Mar; 339(2):218-33. PubMed ID: 4827852
    [No Abstract]   [Full Text] [Related]  

  • 10. Asymmetric binding of steroids to internal and external sites in the glucose carrier of erythrocytes.
    Krupka RM; Devés R
    Biochim Biophys Acta; 1980 May; 598(1):134-44. PubMed ID: 7417422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The binding and translocation steps in transport as related to substrate structure. A study of the choline carrier of erythrocytes.
    Devés R; Krupka RM
    Biochim Biophys Acta; 1979 Nov; 557(2):469-85. PubMed ID: 497194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A study of the dependence of the human erythrocyte glucose transport system on membrane sulfhydryl groups.
    Smith RP; Ellman GL
    J Membr Biol; 1973; 12(2):177-88. PubMed ID: 4205085
    [No Abstract]   [Full Text] [Related]  

  • 13. Structure of cytochalasins and cytochalasin B binding sites in human erythrocyte membranes.
    Rampal AL; Pinkofsky HB; Jung CY
    Biochemistry; 1980 Feb; 19(4):679-83. PubMed ID: 7356953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polyol permeability of the human red cell. Interpretation of glucose transport in terms of a pore.
    Bowman RJ; Lwitt DG
    Biochim Biophys Acta; 1977 Apr; 466(1):68-83. PubMed ID: 856270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phloretinyl-3'-benzylazide: a high affinity probe for the sugar transporter in human erythrocytes. I. Hexose transport inhibition and photolabeling of mutarotase.
    Fannin FF; Evans JO; Gibbs EM; Diedrich DF
    Biochim Biophys Acta; 1981 Dec; 649(2):189-201. PubMed ID: 7198487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anion transport in red blood cells. II. Kinetics of reversible inhibition by nitroaromatic sulfonic acids.
    Barzilay M; Cabantchik ZI
    Membr Biochem; 1979; 2(2):255-81. PubMed ID: 229385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The competitive inhibition of glucose transport in human erythrocytes by compounds of different structures.
    Lacko L; Wittke B
    Biochem Pharmacol; 1982 May; 31(10):1925-9. PubMed ID: 7104025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of glucose transport in human erythrocytes by ubiquinone Q0.
    Lowe AG; Critchley AJ; Brass A
    Biochim Biophys Acta; 1991 Nov; 1069(2):223-8. PubMed ID: 1932061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Testing the simple carrier using irreversible inhibitors.
    Lieb WR; Stein WD
    Biochim Biophys Acta; 1976 Dec; 455(3):913-27. PubMed ID: 999944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of sugar acetals with the human erythrocyte glucose transport system.
    Novak RA; LeFevre PG
    J Membr Biol; 1974 Jul; 17(3):383-90. PubMed ID: 4847765
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.